Pharmaceutical manufacturing

A person wearing a face mask is seen in Melbourne, Australia Monday, Aug. 3, 2020. Australia’s hard-hit Victoria state was declared a disaster with sweeping new coronavirus restrictions imposed across Melbourne and elsewhere from Sunday night. (James Ross/AAP Image via AP)
August 03, 2020 - 3:23 am
CANBERRA, Australia (AP) — Victoria state, Australia’s coronavirus hot spot, announced on Monday that businesses will be closed and scaled down in a bid to curb the spread of the virus. Victoria Premier Daniel Andrews said nonessential businesses will close starting late Wednesday in Melbourne,...
Read More
FILE - In this June 16, 2020, file photo, French President Emmanuel Macron listens to a researcher as he visits an industrial development laboratory at French drugmaker's vaccine unit Sanofi Pasteur plant in Marcy-l'Etoile, near Lyon, central France. As the race for a vaccine against the new coronavirus intensifies, many rich countries are rushing to the front of the line by placing advance orders for the inevitably limited supply to guarantee their citizens are immunized first. (AP Photo/Laurent Cipriani, Pool)
July 31, 2020 - 7:47 am
LONDON (AP) — Pharma giants GlaxoSmithKline and Sanofi Pasteur have announced they will supply 100 million doses of its experimental COVID-19 vaccine to the United States as governments buy up supplies in hopes something will work. The United States will pay up to $2.1 billion “for development...
Read More
FILE- This May 1, 2018, file photo shows Merck corporate headquarters in Kenilworth, N.J. The pandemic increased sales of Merck medicines during the first quarter of 2020, as households around the world stocked up, but the drugmaker expects a significant hit this quarter as the full force of the outbreak lands. (AP Photo/Seth Wenig, File)
July 31, 2020 - 6:52 am
FAIRLESS HILLS, PA (AP) — Surging sales of its cancer medicines and reduced spending across the board helped Merck overcome a big hit from the coronavirus pandemic and increase its profit 12% in the second quarter. The drugmaker boosted its financial forecast for the year Friday even as it spends...
Read More
FILE - In this Saturday, July 18, 2020 file photo a general view of AstraZeneca offices and the corporate logo in Cambridge, England. Scientists at Oxford University say their experimental coronavirus vaccine has been shown in an early trial to prompt a protective immune response in hundreds of people who got the shot. "We are seeing good immune response in almost everybody," said Dr. Adrian Hill. Hill said Oxford has partnered with drugmaker AstraZeneca to produce their vaccine globally, and that the company has already committed to making 2 billion doses. (AP Photo/Alastair Grant, File)
July 30, 2020 - 11:27 am
LONDON (AP) — Pharmaceutical company AstraZeneca repeated its promise not to profit from a COVID-19 vaccine during the pandemic as it reported it was on track with late-stage trials for the treatment. Such promises were boosted by strong sales across its range of treatments during lockdown. Sales...
Read More
Currency trader watch computer monitors near the screen showing the Korea Composite Stock Price Index (KOSPI) at the foreign exchange dealing room in Seoul, South Korea, Thursday, July 30, 2020. Asian stocks advanced Thursday after the U.S. Federal Reserve left interest rates near zero to support a struggling economy. (AP Photo/Lee Jin-man)
July 29, 2020 - 10:49 pm
BEIJING (AP) — Asian stocks advanced Thursday after the U.S. Federal Reserve left interest rates near zero to support a struggling economy. Benchmarks in Shanghai, Tokyo, Hong Kong and Seoul all gained. Lower interest rates and investor optimism about a possible coronavirus vaccine have helped...
Read More
Gao Fu, the head of the Chinese Center for Disease Control and Prevention (China CDC), speaks to journalists after a press conference at the State Council Information Office in Beijing on Jan. 26, 2020. Gao has revealed Tuesday, July 28, 2020 he has been injected with an experimental coronavirus vaccine in what he said is an attempt to persuade the public to follow suit when one is approved. (AP Photo/Mark Schiefelbein)
July 28, 2020 - 1:51 am
BEIJING (AP) — The head of the Chinese Center for Disease Control and Prevention says he has been injected with an experimental coronavirus vaccine in an attempt to persuade the public to follow suit when one is approved. “I’m going to reveal something undercover: I am injected with one of the...
Read More
President Donald Trump speaks during a coronavirus briefing at Bioprocess Innovation Center at Fujifilm Diosynth Biotechnologies, Monday, July 27, 2020, in Morrisville, N.C. (AP Photo/Evan Vucci)
July 27, 2020 - 5:23 pm
WASHINGTON (AP) — President Donald Trump’s handling of the coronavirus pandemic put his political fate in grave jeopardy. Now he’s hoping to get credit for his administration’s aggressive push for a vaccine -– and crossing his fingers that one gets approved before Election Day. Trump and Vice...
Read More
FILE - In this Wednesday, March 4, 2020 file photo, Jon Ossoff speaks to the media and supporters after he qualified to run in the Senate race against Republican Sen. David Perdue in Atlanta. The Democratic Senate candidate is in isolation as is his wife, who contracted COVID-19, Ossoff confirmed Saturday, July 25, 2020. (Bob Andres/Atlanta Journal-Constitution via AP)
July 25, 2020 - 5:22 pm
ATLANTA -- Georgia Democratic Senate candidate Jon Ossoff says he's in isolation with his wife, who contracted COVID-19. The 33-year-old candidate said his wife, Dr. Alisha Kramer, has mild coronavirus symptoms and that he’s showing symptoms, too. He said he was tested Saturday and is awaiting...
Read More
President Donald Trump speaks during an event to sign executive orders on lowering drug prices, in the South Court Auditorium in the White House complex, Friday, July 24, 2020, in Washington. (AP Photo/Alex Brandon)
July 24, 2020 - 8:23 pm
WASHINGTON (AP) — Unable to land the big deal with Congress to curb drug costs, President Donald Trump on Friday moved on his own to allow imports of cheaper medicines, along with other limited steps that could have some election-year appeal. At a White House ceremony, Trump signed four executive...
Read More
File- This Dec. 4, 2017, photo shows the Pfizer company logo at the company's headquarters in New York. The federal government has agreed to pay nearly $2 billion for 100 million doses of a potential COVID-19 vaccine being developed by the U.S. drugmaker and its German partner BioNTech. (AP Photo/Richard Drew, File)
July 22, 2020 - 4:40 pm
WASHINGTON (AP) — The Trump administration will pay Pfizer nearly $2 billion for a December delivery of 100 million doses of a COVID-19 vaccine the pharmaceutical company is developing, Health and Human Services Secretary Alex Azar announced Wednesday. The U.S. could buy another 500 million doses...
Read More

Pages